Suzi Ring Bloomberg
- All
- News
-
AstraZeneca Booster Significantly Boosts Antibodies Against Omicron
A third dose of AstraZeneca Plc's Covid-19 vaccine significantly boosted neutralizing antibody levels against Omicron, according to lab studies at the University of Oxford.
-
Moderna Says Third Dose Boosts Antibodies Against Omicron
A third dose of Moderna Inc.'s Covid-19 vaccine increased antibody levels against the omicron variant, results the company described as reassuring while it works on a shot tailored to the new strain.
-
Omicron vs Vaccines Shows What Scientists Fear In New Study
The omicron variant dented the protection afforded by two doses of Pfizer Inc.'s and AstraZeneca Plc's Covid vaccines as feared, researchers found, increasing the risk of infection.
-
6 Vaccines Show Promise As Boosters, Led By Pfizer And Moderna
A U.K. study testing seven different Covid-19 vaccines as booster doses found most of them increased antibodies, with shots from Moderna Inc. and the Pfizer Inc.-BioNTech SE partnership performing best.
-
Possible New Links Between AstraZeneca Vaccine And Blood Clots
Scientists have identified a possible reason the AstraZeneca Plc Covid-19 vaccine may cause blood clots, after use of the shot was limited globally to prevent the rare side effect.
-
Does Omicron Defeat Vaccines? No Sign Of That Yet, Says Oxford
There's no evidence existing vaccines won't provide some protection against the omicron variant, the University of Oxford said as scientists scramble to assess the new Covid-19 mutation.
-
The Week That Covid Sucker Punched the World
On Monday morning, Austria's near-9 million residents woke to life in lockdown. Days later, a new Covid-19 variant set off alarm bells across the world, Europe and the U.S. slapped a travel ban on countries in Southern Africa.
-
More Severe Covid In Indian Subcontinent May Be Blamed On Gene: Study
Scientists identified a specific gene that doubles the risk of respiratory failure from Covid-19 and may go some way to explaining why some ethnic groups are more susceptible to severe disease than others.
-
Why Even Countries With Successful Vaccine Rate Are Struggling With Delta
People inoculated against COVID-19 are just as likely to spread the delta variant of the virus to contacts in their household as those who haven't had shots, according to new research.
-
AstraZeneca Says Its Antibody Cocktail Prevents Covid In High-Risk Groups
AstraZeneca Plc's Covid-19 antibody cocktail was found to be 77% effective in preventing symptomatic Covid-19 in high-risk people in a key trial that could expand the range of drugs available to vulnerable groups.
-
She Was Co-Infected With 2 Variants, Most Likely From Separate People
A 90-year-old woman died after becoming infected with two different strains of Covid-19, revealing another risk in the fight against the disease, Belgian researchers found.
-
AstraZeneca's Antibody Cocktail Fails to Prevent Covid: Study
AstraZeneca Plc's antibody cocktail was only 33% effective at preventing COVID-19 symptoms in people who had been exposed to the virus, failing a study that was key to the drugmaker's pandemic push.
-
What Happens When You Mix 2 Vaccine Shots? A Study Has Found This
Mixing doses of two leading Covid-19 vaccines increased patients' side effects such as fatigue and headaches in early findings from a study that has yet to show how well such a cocktail defends against the virus.
-
This May Be Dark Horse Of Vaccine Race. It's More "Variant-Proof"
As the battle with Covid-19 rages around the world, a small French biotech has a possible solution for the long-term war against the virus and the rapidly spreading mutations.
-
AstraZeneca Moves From Favored Child To Problem Child Among Vaccines
Mene Pangalos, head of biopharmaceuticals research for AstraZeneca Plc, went to bed on Monday, March 22, feeling good for the first time in a while.
-
AstraZeneca Booster Significantly Boosts Antibodies Against Omicron
A third dose of AstraZeneca Plc's Covid-19 vaccine significantly boosted neutralizing antibody levels against Omicron, according to lab studies at the University of Oxford.
-
Moderna Says Third Dose Boosts Antibodies Against Omicron
A third dose of Moderna Inc.'s Covid-19 vaccine increased antibody levels against the omicron variant, results the company described as reassuring while it works on a shot tailored to the new strain.
-
Omicron vs Vaccines Shows What Scientists Fear In New Study
The omicron variant dented the protection afforded by two doses of Pfizer Inc.'s and AstraZeneca Plc's Covid vaccines as feared, researchers found, increasing the risk of infection.
-
6 Vaccines Show Promise As Boosters, Led By Pfizer And Moderna
A U.K. study testing seven different Covid-19 vaccines as booster doses found most of them increased antibodies, with shots from Moderna Inc. and the Pfizer Inc.-BioNTech SE partnership performing best.
-
Possible New Links Between AstraZeneca Vaccine And Blood Clots
Scientists have identified a possible reason the AstraZeneca Plc Covid-19 vaccine may cause blood clots, after use of the shot was limited globally to prevent the rare side effect.
-
Does Omicron Defeat Vaccines? No Sign Of That Yet, Says Oxford
There's no evidence existing vaccines won't provide some protection against the omicron variant, the University of Oxford said as scientists scramble to assess the new Covid-19 mutation.
-
The Week That Covid Sucker Punched the World
On Monday morning, Austria's near-9 million residents woke to life in lockdown. Days later, a new Covid-19 variant set off alarm bells across the world, Europe and the U.S. slapped a travel ban on countries in Southern Africa.
-
More Severe Covid In Indian Subcontinent May Be Blamed On Gene: Study
Scientists identified a specific gene that doubles the risk of respiratory failure from Covid-19 and may go some way to explaining why some ethnic groups are more susceptible to severe disease than others.
-
Why Even Countries With Successful Vaccine Rate Are Struggling With Delta
People inoculated against COVID-19 are just as likely to spread the delta variant of the virus to contacts in their household as those who haven't had shots, according to new research.
-
AstraZeneca Says Its Antibody Cocktail Prevents Covid In High-Risk Groups
AstraZeneca Plc's Covid-19 antibody cocktail was found to be 77% effective in preventing symptomatic Covid-19 in high-risk people in a key trial that could expand the range of drugs available to vulnerable groups.
-
She Was Co-Infected With 2 Variants, Most Likely From Separate People
A 90-year-old woman died after becoming infected with two different strains of Covid-19, revealing another risk in the fight against the disease, Belgian researchers found.
-
AstraZeneca's Antibody Cocktail Fails to Prevent Covid: Study
AstraZeneca Plc's antibody cocktail was only 33% effective at preventing COVID-19 symptoms in people who had been exposed to the virus, failing a study that was key to the drugmaker's pandemic push.
-
What Happens When You Mix 2 Vaccine Shots? A Study Has Found This
Mixing doses of two leading Covid-19 vaccines increased patients' side effects such as fatigue and headaches in early findings from a study that has yet to show how well such a cocktail defends against the virus.
-
This May Be Dark Horse Of Vaccine Race. It's More "Variant-Proof"
As the battle with Covid-19 rages around the world, a small French biotech has a possible solution for the long-term war against the virus and the rapidly spreading mutations.
-
AstraZeneca Moves From Favored Child To Problem Child Among Vaccines
Mene Pangalos, head of biopharmaceuticals research for AstraZeneca Plc, went to bed on Monday, March 22, feeling good for the first time in a while.
